Pharmaceutical Chemical 99% Lamivudine Powder CAS 134678-17-4 Raw Material Lamivudine

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >99%
• Model NO.: HRK-Lamivudine
• Product Name: Lamivudine Powder
• Appearance: White Powder
• Test: HPLC
• Mf: C8h11n3o3s
• CAS: 134678-17-4
• MW: 229.25
• Active Ingredient: Lamivudine
• Sample: Lamivudine Avaliable
• Certificate: GMP ISO USP Bp
• Assay: 90% Min Lamivudine
• Grade Standard: Feed Grade, Food Grade, Medicine Grade
• Application: Lamivudine Raw Materials
• Type of Product: Auxiliaries and Other Medicinal Chemicals
• Storage: Cool Dry Place
• Shelf Life: 2 Years Proper Storage
• Transport Package: 1kg Per Foil Bag, 10 Bags Per Carton. 25 Kg Per Dr
• Specification: 99% min Lamivudine
• Trademark: Henrikang
• Origin: Shaanxi China
• Production Capacity: 500000kg/Year

Product Description

Pharmaceutical Chemical 99% Lamivudine Powder CAS 134678-17-4 Raw Material Lamivudine

Product Name	Pharmaceutical Chemical 99% Lamivudine Powder CAS 134678-17-4 Raw Material Lamivudine
CAS	134678-17-4
Appearance	White Powder
Assay	98%
Shelf Life	24 months when properly stored
Storage	Keep in a cool, dry, dark location

 

What is Lamivudine ? Lamivudine is a cytidine analog which acts as a potent reverse transcriptase inhibitor (nRTI). Lamivudine is effective against both HIV reverse transcriptase 1 and 2, as well as hepatitis B reverse transcriptase. Lamivudine must be phosphorylated to its triphosphate form before it is active.

Function of Lamivudine

Lamivudine belongs to a class of  "nucleosides reverse transcripts inhibitors" or "NRTIs". Lamivudine mimics a nucleoside
base, which blocks further construction
of the virus. When combined with others, Lamivudine can achieve a significant decrease in viral multiplication.

Application of Lamivudine

1.Lamivudine as for the treatment of hepatobiliary diseases caused by hepatitis B virus infection

2.Lamivudine is used as hepatobiliary disease medication

3.Lamivudine is used as AIDS treatment.

Lamivudine is a new antiviral drug, which belongs to nucleoside reverse transcriptase inhibitor. It has a strong inhibitory
effect on hepatitis B virus (HBV) in vitro and experimental infected animals, and can inhibit the synthesis of HIV virus. Th
e drug is manufactured by GlaxoSmithKline. In the early 1990s, it was used to treat AIDS in some countries in Europe an
d North America. In the mid-1990s, medical experts found that it had an inhibitory effect on the DNA of hepatitis B virus. I
n 1998, the United States Food and Drug Administration (FDA) first approved it as a treatment drug for hepatitis B. China
's State Food and Drug Administration approved the import of the drug mainly used as a hepatitis B treatment, the Chines
e trade name is "heptin", officially began to sell in mainland China in 1999. After 10 years of clinical validation, lamivudine
is currently the only drug that has been proven to delay the progression of hepatitis cirrhosis with fewer side effects and l
ess cost, and is currently being used by 2 million hepatitis B patients nationwide.

 

Pharmaceutical Chemical 99% Lamivudine Powder CAS 134678-17-4 Raw Material Lamivudine    
Lamivudine;Lamivudine Powder;Lamivudine Raw Material